FI933231A - Acylaminoalkylidenhydroxibisfosfonsyror anvaendningsbara vid terapi av benledsjukdomar - Google Patents

Acylaminoalkylidenhydroxibisfosfonsyror anvaendningsbara vid terapi av benledsjukdomar Download PDF

Info

Publication number
FI933231A
FI933231A FI933231A FI933231A FI933231A FI 933231 A FI933231 A FI 933231A FI 933231 A FI933231 A FI 933231A FI 933231 A FI933231 A FI 933231A FI 933231 A FI933231 A FI 933231A
Authority
FI
Finland
Prior art keywords
pct
terapi
benledsjukdomar
anvaendningsbara
acylaminoalkylidenhydroxibisfosfonsyror
Prior art date
Application number
FI933231A
Other languages
English (en)
Other versions
FI933231A0 (fi
FI105403B (fi
Inventor
Sergio Rosini
Maurizio Mian
Original Assignee
Gentili Ist Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentili Ist Spa filed Critical Gentili Ist Spa
Publication of FI933231A publication Critical patent/FI933231A/fi
Publication of FI933231A0 publication Critical patent/FI933231A0/fi
Application granted granted Critical
Publication of FI105403B publication Critical patent/FI105403B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572Five-membered rings
    • C07F9/5728Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Lubricants (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI933231A 1991-02-01 1993-07-16 Analogiamenetelmä lääkeaineina käyttökelpoisten asyyliamino-alkylideeni-hydroksi-bisfosfonihappojen valmistamiseksi FI105403B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ITMI910254A IT1244698B (it) 1991-02-01 1991-02-01 Acidi aril-o arilalchil-acil ammino-alchil-idrossidifosfonici, procedimento per la loro preparazione e loro uso in terapia osteo-articolare e dei tessuti connettori in generale
ITMI910254 1991-02-01
PCT/EP1992/000102 WO1992013864A1 (en) 1991-02-01 1992-01-20 Acylamino-alkyliden-hydroxy-bisphosphonic acids useful in the therapy of osteoarticular diseases
EP9200102 1992-01-20

Publications (3)

Publication Number Publication Date
FI933231A true FI933231A (fi) 1993-07-16
FI933231A0 FI933231A0 (fi) 1993-07-16
FI105403B FI105403B (fi) 2000-08-15

Family

ID=11358376

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933231A FI105403B (fi) 1991-02-01 1993-07-16 Analogiamenetelmä lääkeaineina käyttökelpoisten asyyliamino-alkylideeni-hydroksi-bisfosfonihappojen valmistamiseksi

Country Status (20)

Country Link
US (1) US5466682A (fi)
EP (1) EP0569411B1 (fi)
JP (1) JP3046624B2 (fi)
KR (1) KR100190911B1 (fi)
AT (1) ATE120464T1 (fi)
AU (1) AU653780B2 (fi)
CA (1) CA2101548C (fi)
CZ (1) CZ288731B6 (fi)
DE (1) DE69201863T2 (fi)
DK (1) DK0569411T3 (fi)
ES (1) ES2069990T3 (fi)
FI (1) FI105403B (fi)
HK (1) HK1006311A1 (fi)
HU (2) HU215918B (fi)
IT (1) IT1244698B (fi)
MX (1) MX9200452A (fi)
PT (1) PT100075B (fi)
RU (1) RU2079505C1 (fi)
SK (1) SK280053B6 (fi)
WO (1) WO1992013864A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6054587A (en) * 1997-03-07 2000-04-25 Metabasis Therapeutics, Inc. Indole and azaindole inhibitors of fructose-1,6-bisphosphatase
AU6452098A (en) 1997-03-07 1998-09-22 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
HUP0300227A2 (hu) * 2003-01-28 2004-09-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás nagy tisztaságú 2-szubsztituált -1-(hidroxi-etilidén)-1,1-biszfoszfonsavak és sóik előállítására

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2530139C3 (de) * 1975-04-30 1979-06-21 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen N-Acyl-1 -aminoalkan-1,1 -diphosphonsäuren, deren Herstellung und Verwendung
DE2651904C2 (de) * 1976-11-13 1983-01-05 Joh. A. Benckiser Gmbh, 6700 Ludwigshafen Verfahren zur Herstellung von N-Acyl-N-alkylaminomethandiphosphonsäuren
DE3203308A1 (de) * 1982-01-27 1983-07-28 Schering Ag, 1000 Berlin Und 4619 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
EP0084822B1 (de) * 1982-01-27 1986-01-08 Schering Aktiengesellschaft Diphosphonsäure-Derivate und diese enthaltende pharmazeutische Präparate
FR2531088B1 (fr) * 1982-07-29 1987-08-28 Sanofi Sa Produits anti-inflammatoires derives de l'acide methylenediphosphonique et leur procede de preparation
DE3512536A1 (de) * 1985-04-06 1986-10-16 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeure-derivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
ES2039237T3 (es) * 1986-04-24 1993-09-16 Fujisawa Pharmaceutical Co., Ltd. Procedimiento para preparar nuevos compuestos de acido difosfonico.
DE3623397A1 (de) * 1986-07-11 1988-01-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
JPH0778024B2 (ja) * 1988-10-14 1995-08-23 藤沢薬品工業株式会社 医薬化合物とジホスホン酸誘導体の結合体を含有する医薬用製剤
PH26923A (en) * 1989-03-08 1992-12-03 Ciba Geigy N-substituted amino alkanediphosphonic acids
US5159108A (en) * 1990-09-18 1992-10-27 Merck & Co., Inc. Process for preparing an antihypercalcemic agent

Also Published As

Publication number Publication date
WO1992013864A1 (en) 1992-08-20
EP0569411A1 (en) 1993-11-18
IT1244698B (it) 1994-08-08
HUT64964A (en) 1994-03-28
RU2079505C1 (ru) 1997-05-20
EP0569411B1 (en) 1995-03-29
PT100075B (pt) 1999-06-30
DE69201863T2 (de) 1995-09-07
HU9302188D0 (en) 1993-10-28
CA2101548C (en) 2002-08-27
AU653780B2 (en) 1994-10-13
HU211203A9 (en) 1995-11-28
CZ153393A3 (en) 1994-01-19
SK280053B6 (sk) 1999-07-12
JP3046624B2 (ja) 2000-05-29
US5466682A (en) 1995-11-14
ITMI910254A1 (it) 1992-08-01
KR100190911B1 (ko) 1999-06-01
AU1170992A (en) 1992-09-07
DK0569411T3 (da) 1995-08-28
CZ288731B6 (cs) 2001-08-15
SK79993A3 (en) 1993-12-08
FI933231A0 (fi) 1993-07-16
CA2101548A1 (en) 1992-08-02
HU215918B (hu) 1999-03-29
FI105403B (fi) 2000-08-15
JPH06504783A (ja) 1994-06-02
ES2069990T3 (es) 1995-05-16
DE69201863D1 (de) 1995-05-04
HK1006311A1 (en) 1999-02-19
ATE120464T1 (de) 1995-04-15
PT100075A (pt) 1993-03-31
ITMI910254A0 (it) 1991-02-01
MX9200452A (es) 1992-08-01

Similar Documents

Publication Publication Date Title
DE69522947T2 (de) Phenylxanthin-derivate
KR960701051A (ko) 이미다조피리딘 및 이를 위장 질환의 치료에 사용하는 방법(imidazopyridines and their use in treating castrointestinal diseases)
ATE184598T1 (de) Enniatine und enniatinderivate zur bekämpfung von endoparasiten
DE69705300T2 (de) Cyclopropylalkansäurederivate
ATE60759T1 (de) Bisdimethoxymethyl(trimethoxybenzyl)isochinolinium salze, ihre herstellung und diese enthaltende pharmazeutische zusammensetzungen.
DK0623021T3 (da) 4"-deoxyerythromycinderivater
FI972434A0 (fi) Lamotrigiiniä sisältävä farmaseuttinen koostumus
SE8207224L (sv) Nya aromatiska aminoalkoxiderivat, deras framstellning och deras terapeutiska anvendning
IL97277A0 (en) Beta-phenylisoserine derivative,and its preparation and application
FI933231A (fi) Acylaminoalkylidenhydroxibisfosfonsyror anvaendningsbara vid terapi av benledsjukdomar
ES2094638T3 (es) N-acilpirrolidinas y medicamentos para el tratamiento o la prevencion de los desordenes relacionados con la colecistoquinina y la gastrina.
FI933925A (fi) N-((4,5-dihydroxi- och 4,5,8-trihydroxi-9,10-dihydro-9,10-dioxo-2-antracenyl)karbonyl)aminosyror, vilka aer anvaendbara foer vaord av benledsjukdomar
NO950177L (no) Farmakologisk aktive erivater
ES2120445T3 (es) 5-mercaptotiazoles aminoalquil-substituidos, su obtencion y empleo.
ES2087567T3 (es) Derivados antibioticos de 7'-amino-naftazarina.
ES2125893T3 (es) 2-amino-1,3,4-tiadiazoles aminoalquilsubstituidos, su obtencion y su empleo.